Health Service Focus

05.12.16

Fast-tracking drugs through streamlined collaboration

Source: NHE Nov/Dec 16

An ongoing consultation by NICE and NHS England is proposing a series of important changes to the way the bodies appraise new drugs and technologies in the country. NHE’s Luana Salles reports.

NHS England and NICE have kick-started a 12-week joint consultation on proposed changes to how the bodies evaluate and fund drugs and other health technologies, including plans to work more closely together to speed up appraisals processes. 

The changes seek to overhaul and simplify the arrangements for reviewing drugs through NICE’s Technology Appraisal and Highly Specialised Technologies programmes, such as by introducing a ‘fast-track’ system for the most promising new technologies in order to get treatments to patients faster, or determining new ‘budget impact thresholds’. 

Fast-tracking 

The fast-track system will account for technologies that fall below an incremental cost-effectiveness ratio of £10,000 per QALY (quality-adjusted life year), meaning a “confident judgement about value for money” can be made at an early stage. This accelerated route would be a variant of the standard technology appraisal process, cutting the time it takes to make an evidence submission through to the publication of final guidance from 43 to 32 weeks. At present, around 15% of NICE’s technology appraisals fall at or below £10,000 per QALY in the final guidance. 

The criteria for using this proposed route would include the availability of strong evidence that products are cost-effective, and an estimate that the new technology would fall under the proposed budget impact threshold for the full patient population relevant to the appraisal. Companies would be able to indicate that they want their products to follow a fast-track appraisal, after which NICE would analyse the submission and decide whether or not the fast route is appropriate. 

Fast-tracked technologies that fall under these pre-determined goalposts would then be provided with access to NHS funding within 30 days of the publication of final guidance, rather than the current 90. NICE estimates that using this new route would result in a 25% saving in process time compared with standard appraisals. 

Dr Jonathan Fielden, NHS England’s director of specialised commissioning and deputy national medical director, argued the fast-track process will “significantly speed up access”, making it good for patients, taxpayers and pharmaceutical companies “willing to work with us and price their products responsibly”. 

New budget thresholds 

The consultation, which closes on 13 January, also mooted a new budget impact threshold of £20m per year, which would apply to treatments deemed cost-effective but that still have a very high cost. This threshold will both trigger discussions about potential ‘commercial agreements’ between NHS England and companies, and will help decide the circumstances in which NHS England may ask NICE to consider varying the standard 90-day limit that providers have to make funding for recommended treatments available. Around 80% of treatments appraised by NICE fall below this proposed threshold. 

It has also been suggested that NICE and NHS England’s separate processes for evaluating highly specialised technologies could be linked. For this, the bodies recommended automatically funding, from routine commissioning budgets, treatments for very rare conditions up to £100,000 per QALY – five times greater than the lower end of NICE’s standard threshold range – while also providing the opportunity for treatments above this range to be considered through NHS England’s own process. 

Agile and flexible 

Sir Andrew Dillon, NICE’s chief executive, argued that these headline proposals form part of a desire to be “more agile and flexible” in the way decisions are made about new drugs, devices and diagnostics. 

“The pace and scale of innovation in the NHS require NICE and NHS England to collaborate closely to ensure patients are benefiting from faster access to the most cost effective treatments,” he added. 

“By further streamlining our processes we will ensure treatments that clearly offer exceptional value for money will be available to the patients who need them faster than ever before. Where the introduction of a new treatment places a large, immediate demand on NHS budgets, the impact of their introduction on other services has to be taken into account in managing their adoption. 

“NICE and NHS England believe these proposals represent a fair approach to the significant challenge of providing faster access to innovative, cost-effective treatments alongside the need to safeguard future financial sustainability.”

For more information

To take part in the consultation, visit:

W: www.tinyurl.com/NHE-NICE-consultation

Tell us what you think – have your say below or email opinion@nationalhealthexecutive.com

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

Three CCGs slapped with NHS England legal directions

18/08/2017Three CCGs slapped with NHS England legal directions

Three CCGs have been slapped with NHS England legal directions requiring them to produce urgent improvement and financial plans, as well as hire ... more >
Numbers placed into nursing courses drops by 8% since 2016

18/08/2017Numbers placed into nursing courses drops by 8% since 2016

Nurses have today warned that there are not enough new workers being trained to keep pace with demand as UCAS figures showed that there had been ... more >
London trust told to improve for third time in three years

17/08/2017London trust told to improve for third time in three years

A major London NHS trust has been told by inspectors that it needs to urgently improve after it received its third ‘Requires Improvement&rs... more >

editor's comment

13/06/2017Tackling the major challenges facing the NHS

As you will have gathered from the front cover, a theme that runs throughout this edition of NHE is about empowering and involving the workforce in order to deliver innovative change across the system.  Professor Jane Dacre, president of the Royal College of Physicians, highlights on page 16 the importance of sustainability and trans... read more >

last word

Your personality, your leadership

Your personality, your leadership

Deirdre Wallace, clinical skills manager at UCL Medical School, discusses the importance of learning about leadership and self while at medical school. Approximately five years ago, I was ch... more > more last word articles >
681 149x260 NHE Subscribe button

the scalpel's daily blog

Turbo-boosting STPs? It’s time we got serious about ‘partnership’

27/07/2017Turbo-boosting STPs? It’s time we got serious about ‘partnership’

Merron Simpson, chief executive New NHS Alliance, argues we’re missing the point of what ‘partnership working’ truly means if we refuse to recruit help from those outside the health service. Jeremy Hunt and Simon Steven’s recent announcement to ‘turbo-boost’ sustainability and transformation partnerships (STPs) provides a welcome shot-in-the-arm for those across the system who are ... more >
read more blog posts from 'the scalpel' >

comment

Changing our digital culture and safeguarding patient data

08/08/2017Changing our digital culture and safeguarding patient data

Joanna Smith, chief information officer at Royal Brompton & Harefield NHS FT (RBHT), says that as the NHS becomes more digital it has to get ... more >
A centre for medicines optimisation research and education

04/08/2017A centre for medicines optimisation research and education

Dr Yogini Jani, a consultant pharmacist at University College London Hospitals NHS FT (UCLH), discusses a collaboration with UCL School of Pharma... more >
Unlocking the benefits of age-friendly cities

04/08/2017Unlocking the benefits of age-friendly cities

Stefanie Buckner, Calum Mattocks and Louise Lafortune from the Cambridge Institute of Public Health, alongside Melanie Rimmer from the School of ... more >
A community service

04/08/2017A community service

Louise Watson, NHS England director of the New Care Models programme, discusses the emerging success stories from the vanguard areas across the c... more >
Diabetes Professional Care launches 2017 Conference programme

03/08/2017Diabetes Professional Care launches 2017 Conference programme

An outstanding line-up of practitioners and thought leaders will share their expertise and knowledge with healthcare professionals from across th... more >

interviews

Improving care at the touch of a screen

08/08/2017Improving care at the touch of a screen

When it comes to dementia, having a calm and safe environment can have a substantial impact on a patient’s quality of life. NHE’s Jos... more >
A new approach to talent management

25/07/2017A new approach to talent management

Martin Hancock, national lead for talent management at NHS Leadership Academy, and Gill Rooke, the organisation’s senior operations manager... more >
Enabling greater integration through ACSs

25/07/2017Enabling greater integration through ACSs

At this year’s NHS Confed, Simon Stevens revealed the first wave of accountable care systems (ACSs). NHE speaks to Ian Dodge, the director ... more >
How NHS organisations can protect themselves against cyber crime

25/07/2017How NHS organisations can protect themselves against cyber crime

On 12 May, a global cyber-attack occurred on an unprecedented scale. It affected organisations across the globe and, though it did not specifical... more >
Working collectively to improve cancer outcomes for patients

20/06/2017Working collectively to improve cancer outcomes for patients

Last year, the cancer vanguard established the Pharma Challenge. Rob Duncombe, pharmacy director at the Christie NHS FT, gives NHE an update on t... more >